Detsky A S, McLaughlin J R, Abrams H B, L'Abbe K A, Whitwell J, Bombardier C, Jeejeebhoy K N
J Gen Intern Med. 1986 Jan-Feb;1(1):26-33. doi: 10.1007/BF02596321.
Quality of life and quality-adjusted survival were measured for a cohort of 73 patients maintained on long-term parenteral nutrition at home (HPN) for periods ranging from six months to 12 years. Quality-adjusted survival was also modeled (although not directly observed) for this cohort under alternative therapeutic strategies (e.g., parenteral nutrition in hospital as needed). Using three utility assessment techniques (category scaling, time-tradeoff, direct questioning of objectives), quality of life was measured through interviews with 37 patients. The quality of life of the patients interviewed was good (mean value 0.73 where 0 represents death and 1.0 represents perfect health); for those who had experienced a period of chronic malnutrition before HPN, quality of life had improved. For the entire cohort, the estimate of quality-adjusted survival was four times greater with HPN than with the alternative therapeutic strategies (p less than 0.001). In comparison with alternative strategies, HPN significantly improves the quality of life of patients unable to sustain themselves with oral alimentation. Quality of life (utility) techniques can be used to evaluate the effectiveness of interventions for patients with chronic diseases.
对一组73例在家中接受长期肠外营养(HPN)达6个月至12年的患者进行了生活质量和质量调整生存期的评估。还对该队列在替代治疗策略(如根据需要在医院进行肠外营养)下的质量调整生存期进行了建模(尽管未直接观察到)。使用三种效用评估技术(类别量表、时间权衡、直接询问目标),通过对37例患者的访谈来测量生活质量。接受访谈患者的生活质量良好(平均值为0.73,其中0代表死亡,1.0代表完美健康);对于那些在接受HPN之前经历过一段慢性营养不良时期的患者,生活质量有所改善。对于整个队列,HPN的质量调整生存期估计值比替代治疗策略高出四倍(p小于0.001)。与替代策略相比,HPN显著提高了无法通过口服营养维持自身的患者的生活质量。生活质量(效用)技术可用于评估对慢性病患者干预措施的有效性。